Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1623-1626
Published online before print March 12, 2009, doi: 10.1161/STROKEAHA.108.523431
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/1623    most recent
STROKEAHA.108.523431v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pieters, B.
Right arrow Articles by Lodder, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pieters, B.
Right arrow Articles by Lodder, J.
Related Collections
Right arrow Cerebral Lacunes
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Pathology of Stroke

(Stroke. 2009;40:1623.)
© 2009 American Heart Association, Inc.


Original Contributions

Periventricular White Matter Lucencies Relate to Low Vitamin B12 Levels in Patients With Small Vessel Stroke

Barbe Pieters, MD; Julie Staals, MD; Iris Knottnerus, MD; Rob Rouhl, MD; Paul Menheere, MD, PhD; AlFons Kessels, MD, MSc Jan Lodder, MD, PhD

From Departments of Neurology (B.P., J.S., I.K., R.R., J.L.), Clinical Chemistry (P.M.), Clinical Epidemiology and Medical Technology Assessment (A.K.), University Hospital Maastricht, the Netherlands.

Correspondence to Dr Jan Lodder, Department of Neurology, University Hospital Maastricht, PO Box 5800, 6202 AZ, Maastricht, the Netherlands. E-mail j.lodder{at}mumc.nl

Background and Purpose— Blood–brain barrier dysfunction may be an early phenomenon in the development of the small vessel disease, which underlies white matter lesions. Because vitamin B12 plays a role in maintaining the integrity of the blood–brain barrier, we studied serum vitamin B12 level in relation to such lesions.

Methods— In 124 patients with first lacunar stroke, we measured serum vitamin B12 level and rated the degree of white matter lesions on MRI.

Results— Mean vitamin B12 level was 202 pmol/L (SD, 68.9). Thirty-nine patients (31.5%) had a vitamin B12 level less than the lower reference value of 150 pmol/L. Lower vitamin B12 level was (statistically significant) associated with more severe periventricular white matter lesions (odds ratio/100 pmol/L decrease, 1.773; 95% CI, 1.001–3.003), but not with deep white matter lesions (odds ratio/100 pmol/L decrease, 1.441; 95% CI, 0.881–2.358; ordered multivariate regression analysis).

Conclusions— More severe periventricular white matter lesions in lacunar stroke patients relate to lower vitamin B12 levels. A possible causal relationship should now be studied prospectively.


Key Words: lacunar stroke • vitamin B12 • white matter lesions